3' Blocking Groups for Specific PCR Amplification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Polymerase Chain Reaction (PCR) amplification is hindered by non-specific sequence amplification due to mis-priming of PCR primers, which reduces the efficiency of target sequence amplification.
Innovation Solution
The use of modified nucleotides and primers with 3′ blocking groups that are removed to initiate PCR, preventing premature extension and ensuring specific amplification of target sequences.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If standard PCR primers are used without blocking groups, then amplification proceeds rapidly, but non-specific amplification and mis-priming occur reducing target sequence efficiency
Solution Approach 1:
The patent applies preliminary action by incorporating 3′ blocking groups on nucleotides within the primers before the PCR reaction begins. These blocking groups prevent premature extension and mis-priming during reagent mixing and incubation at lower temperatures. The blocking groups are then removed in-situ during the initial denaturation step at high temperature, allowing specific amplification to proceed. This preliminary modification of the primers with blocking groups resolves the contradiction by ensuring specificity is maintained during setup while allowing rapid amplification to occur once the blocks are removed.
2Reliability
If hot-start strategies using antibodies or aptamers are used to prevent mis-priming, then specificity improves, but reaction complexity and cost increase
Solution Approach 1:
The patent extracts the hot-start function from external reagents (antibodies, aptamers, or chemical modifications of polymerase) and integrates it directly into the primer structure itself through 3′ blocking groups. This eliminates the need for separate hot-start reagents or modified polymerases, reducing reaction complexity while maintaining the specificity benefit. The blocking groups are simple chemical modifications that can be incorporated during primer synthesis, making the system simpler and more cost-effective while achieving the same specificity improvement.
3Reliability
If 3′ blocking groups are incorporated into primers to prevent mis-priming, then amplification specificity improves, but primer design and synthesis complexity increases
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of the terminal nucleotides of the primers to include removable blocking groups at the 3′ position. These blocking groups (such as allyl, indole, or other photolabile groups) are incorporated during standard oligonucleotide synthesis using modified phosphoramidite chemistry. The modification is made to a single position (the 3′ end) rather than throughout the entire primer, minimizing the impact on synthesis ease while achieving the desired specificity improvement. The blocking groups are designed to be removable under standard PCR conditions without requiring special synthesis procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the specificity and efficiency of PCR by preventing non-specific amplification, as demonstrated by robust amplification results in the presence of target nucleic acids and the absence of primer-dimers.
Implementation Method 1
one or more of which impair or block function of the nucleic acid polymerase
Implementation Method 2
removing the 3′ blocking groups
Data Source
AI summary
Provided herein is a method of amplifying nucleic acids using a plurality of modified nucleotides one or more of the nucleotides comprising a 3′ blocking group. Also provided is a method of amplifying nucleic acids using oligonucleotide primers one or both of the primers comprising a 3′ blocking group on one or more of the nucleotides of the primers.